Phase I, HIV vaccine clinical trial
This study is assessing the safety and immune response of 3 experimental mRNA HIV vaccines in healthy, HIV negative adults between the ages of 18 to 55. This study is currently enrolling participants.
3 Blackfan Circle
Boston, MA 02115 – USA
Beth Israel Deaconess Medical Center
Harvard University School of Medicine